Latest news
After T-DXd: Why Switching ADC Targets May Not Be Enough - OncodailyOncodaily · Sun, 09 Aug 2026 13:59:31 GMTNorstella launches Atlas, an agentic AI platform built on biopharma's most connected data - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 13:40:41 GMTParsortix study shows promise for ADC target detection - PharmaTimesPharmaTimes · Mon, 03 Aug 2026 10:54:03 GMTUnderstanding the toxicology endpoints that matter in ADC development - Drug Target ReviewDrug Target Review · Mon, 03 Aug 2026 06:23:53 GMTCelLBxHealth’s Parsortix® Platform Validated in Peer-Reviewed Study for Detecting ADC Targets on Circulating Tumor Cells in Breast and Ovarian Cancer - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 06:01:47 GMTCellbxhealth plc Uses Parsortix Platform to Detect Adc-Relevant Targets on Circulating Tumour Cells from Breast and Ovarian Cancer Patients - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 06:00:00 GMT